Home › Atherosclerosis › California › Torrance
Atherosclerosis clinical trials in Torrance, CA
4 studies for Atherosclerosis are looking for participants at sites in and around Torrance (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
RecruitingPhase 2
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
RecruitingPhase 3
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
RecruitingPhase 3
- UCLA South Bay Endocrinology, Torrance
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, Torrance
About Atherosclerosis
Atherosclerosis is hardening and narrowing of the arteries caused by the buildup of a fatty substance called plaque. Learn about the risks and prevention.
More about Atherosclerosis on MedlinePlus
Atherosclerosis trials in other cities
- Boston, MA9 studies
- Houston, TX7 studies
- Washington, DC7 studies
- Durham, NC6 studies
- Hialeah, FL6 studies
- San Diego, CA5 studies
- Santa Monica, CA5 studies
- Minneapolis, MN5 studies
- Omaha, NE5 studies
- Dallas, TX5 studies
- Memphis, TN5 studies
- Tucson, AZ5 studies
Other studies in Torrance
- Non-Small Cell Lung Cancer12 studies
- Breast Cancer11 studies
- Bladder Cancer8 studies
- Obesity8 studies
- Overweight8 studies
- Cardiovascular Disease7 studies
- Schizophrenia7 studies
- Lung Cancer7 studies
- Metastatic Cancer6 studies
- Coronary Artery Disease4 studies
- Heart Failure4 studies
- Type 2 Diabetes4 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.